CYP2C19 genetic variation and individualized clopidogrel prescription in a cardiology clinic

• 主要な著者: Seyed abbas Mirabbasi (著者), Koroush Khalighi (著者), Yin Wu (著者), Stanley Walker (著者), Bahar Khalighi (著者), Wuqiang Fan (著者), Archana Kodali (著者), Gang Cheng (著者)
• フォーマット: 図書
• 出版事項: Greater Baltimore Medical Center, 2017-07-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: Clopidogrel (Plavix) is an antiplatelet medication that is routinely used in patients with cardiovascular disease. Cytochrome P2C19 enzymes play a major role in its metabolism, which determines its varied therapeutic level and its effectiveness. Objectives: To customize clopidogrel thera...